← PIQ

PIQPROTEOMICS INTERNATIONAL LABORATORIES LTD

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
13 Aug 2026, 18:46Australian patent for PromarkerEndoCompany UpdateMS11001
5 Aug 2026, 18:17Change in substantial holdingSubstantial Holders—02002
27 July 2026, 19:48Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
23 July 2026, 19:29Webinar Presentation - Healius distribution agreementPresentations—03026
22 July 2026, 18:30Proteomics signs national distribution deal with HealiusCompany UpdateMS11001, 14014
13 July 2026, 18:24Application for quotation of securities - PIQOther—06020
8 July 2026, 20:09US patent secured for PromarkerEndoCompany UpdateMS11001
7 July 2026, 19:07Notification of cessation of securities - PIQOther—06027
4 July 2026, 03:28Response to ASX Price QueryASX QueryMS17003
2 July 2026, 21:52Change of Registered Office AddressSecurities Administration—12003
3 June 2026, 19:59Application for Quotation of Securities - PIQOther—06020
7 May 2026, 23:18Response to ASX Price QueryASX QueryMS17003
1 May 2026, 20:07Notification of Expiry of Listed Options - PIQOCompany Administration—06009, 12008, 16002
28 Apr 2026, 19:13Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
28 Apr 2026, 18:59Proteomics Strategic PlanPresentationsMS03026
18 Apr 2026, 00:37Final Director's Interest NoticeDirector Interests—02010
17 Apr 2026, 19:21Restructure, Executive Appointment and Board UpdateCompany AdministrationMS12001, 12008
25 Feb 2026, 19:43Appendix 4D and Interim Financial ReportFinancial ResultsMS03004, 03009, 03010, 03015, 03019
24 Feb 2026, 03:32Final Director's Interest NoticeCompany Administration—02010, 12001
5 Feb 2026, 20:11Resignation of Joint Company SecretaryCompany Administration—12007
2 Feb 2026, 21:42Application for quotation of securities - PIQOther—06020
30 Jan 2026, 19:25Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19002, 19007
22 Jan 2026, 02:30Application for quotation of securities - PIQOther—06020
19 Jan 2026, 21:05Initial Director's Interest NoticeDirector Interests—02008
16 Jan 2026, 19:22Canadian patent secured for PromarkerEso test for EACCompany UpdateMS11001
16 Jan 2026, 19:20Application for quotation of securities - PIQOther—06020
14 Jan 2026, 19:44Appointment of CEO and Managing DirectorOtherMS12019
12 Jan 2026, 21:23Application for quotation of securities - PIQOther—06020
9 Jan 2026, 22:08Notification of cessation of securities - PIQOther—06027
24 Dec 2025, 21:15Proteomics US lab CAP accredited - extends precision Dx labCompany UpdateMS11001
22 Dec 2025, 19:38Application for quotation of securities - PIQOther—06020
17 Dec 2025, 19:33US patent secured for PromarkerEso diagnostic test for EACCompany UpdateMS11001
16 Dec 2025, 19:45PromarkerD changes how Doctors manage DKD - study publishedCompany Update—11001
15 Dec 2025, 19:21PromarkerD predicts risk of DKD in Aboriginal AustraliansCompany UpdateMS11001
12 Dec 2025, 20:59Investor presentation - TSN ASX Gems ConferencePresentations—03026
3 Dec 2025, 02:52Response to ASX Price QueryASX QueryMS17003
26 Nov 2025, 20:58US Medicare sets reimbursement price for PromarkerD DKD testCompany UpdateMS11001
26 Nov 2025, 20:29Application for quotation of securities - PIQOther—06020
26 Nov 2025, 20:27Notification regarding unquoted securities - PIQOther—06021
26 Nov 2025, 19:32Change of Director's Interest Notice x3Director Interests—02009
26 Nov 2025, 19:29Notification of cessation of securities - PIQOther—06027
24 Nov 2025, 19:37OxiDx test correlates with superior racehorse performanceCompany UpdateMS11001
22 Nov 2025, 01:46Results of MeetingMeetings & Governance—08003
21 Nov 2025, 22:51AGM Chair's Address and Company PresentationCompany Administration—12008, 15002
18 Nov 2025, 21:55Investor presentation - Bell Potter Healthcare ConferencePresentations—03026, 15002
12 Nov 2025, 20:04Proteomics International receives $2.2m in R&D tax incentivePeriodic ReportsMS03014
7 Nov 2025, 00:51PromarkerEndo test for endometriosis receives $0.5m grantCompany UpdateMS03014, 11001
27 Oct 2025, 20:50Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19001, 19006
23 Oct 2025, 01:21Notice of Annual General Meeting/Proxy FormMeetings & Governance—08001, 08004, 16002
15 Oct 2025, 22:00Initial Directors Interest NoticeDirector Interests—02008
1–50 of 65
1 / 2